THE INFLUENCE OF RENAL-INSUFFICIENCY AND HEMODIALYSIS ON THE KINETICS OF CIPROFIBRATE

被引：12

作者：

FERRY, N ^{[1
]}

BERNARD, N ^{[1
]}

POZET, N ^{[1
]}

GARDES, E ^{[1
]}

CUISINAUD, G ^{[1
]}

LABEEUW, M ^{[1
]}

ZECH, PY ^{[1
]}

SASSARD, J ^{[1
]}

机构：

[1] HOP EDOUARD HERRIOT,NEPHROL CLIN,INSERM,U80,F-69437 LYONS 03,FRANCE

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 28卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb03560.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：675 / 681

页数：7

共 17 条

[1] EFFECT OF CIPROFIBRATE TREATMENT ON BILIARY LIPIDS IN PATIENTS WITH HYPERLIPOPROTEINEMIA [J].

ANGELIN, B ;

EINARSSON, K ;

LEIJD, B .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (01) :73-78

[2] RESULTS OF ANIMAL STUDIES WITH CIPROFIBRATE, A NEW ORALLY EFFECTIVE HYPOLIPIDEMIC DRUG [J].

ARNOLD, A ;

MCAULIFF, JP ;

POWERS, LG ;

PHILLIPS, DK ;

BEYLER, AL .

ATHEROSCLEROSIS, 1979, 32 (02) :155-163

[3]

BAGDADE J, 1976, J LIPID RES, V11, P583

[4]

BROWN DF, 1979, AM J CARDIOL, V43, P409

[5]

CAYEN MN, 1983, PROG DRUG METAB, V7, P173

[6]

DAVIGNON J, 1982, LIPOPROTEIN CORONARY

[7]

DAVISON C, 1975, DRUG METAB DISPOS, V3, P520

[8] BLOOD-LEVELS, TISSUE DISTRIBUTION AND THE DURATION OF ACTION IN RATS OF CIPROFIBRATE - NEW HYPOLIPIDEMIC AGENT [J].

EDELSON, J ;

BENZIGER, DP ;

ARNOLD, A ;

BEYLER, AL .

ATHEROSCLEROSIS, 1979, 33 (03) :351-357

[9] IDENTIFICATION OF A MAJOR METABOLITE OF NEW HYPOLIPEMIC AGENT, ISOPROPYL 2-[4'(P-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPIONATE (PROCETOFENE) IN HUMANS BY GAS CHROMATOGRAPHY MASS SPECTROMETRY [J].

ELSOM, LF ;

HAWKINS, DR ;

CHASSEAUD, LF .

JOURNAL OF CHROMATOGRAPHY, 1976, 123 (02) :463-467

[10] PLASMA HALF-LIFE OF CLOFIBRIC ACID IN RENAL-FAILURE [J].

FAED, EM ;

MCQUEEN, EG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (04) :407-410

← 1 2 →